Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial - Khan, AA; Rubin, MR; Schwarz, P (J Bone Miner Res, 2023)
et al.